![](/img/cover-not-exists.png)
90Y-ibritumomab tiuxetan followed by reduced-intensity conditioning and allo-SCT in patients with advanced follicular lymphoma
Abou-Nassar, K E, Stevenson, K E, Antin, J H, McDermott, K, Ho, V T, Cutler, C S, LaCasce, A S, Jacobsen, E D, Fisher, D C, Soiffer, R J, Alyea, E P, Koreth, J, Freedman, A SVolume:
46
Language:
english
Journal:
Bone Marrow Transplantation
DOI:
10.1038/bmt.2010.339
Date:
December, 2011
File:
PDF, 377 KB
english, 2011